Tao Guanhong, deputy director of Suzhou High-tech Zone Management Committee, came to our company for investigation and research

On August 14, Tao Guanhong, deputy director of Suzhou High-tech Zone Management Committee, Gu Caiya, director of District Science and Technology Innovation Bureau, Shen Peiying, deputy director, Li Wei, director of Venture Park and other leaders came to visit and investigate Big Vision to understand the product technology and development of the company, and care about the practical problems encountered in the development of the company and the support needed to be given. Company chairman Chen Xinjian, deputy general manager Duan Ge and other accompanied the visit.

Mr. Duan reported the product technology, core team and development history of Big Vision, and introduced MIAS, the first dual-modality ophthalmic imaging artificial intelligence assisted diagnosis system developed by Big Vision. MIAS has the advantage of integrating OCT 3D images and fundus 2D images, and can perform more accurate analysis of more fundus diseases, and can achieve the auxiliary diagnosis of more than 20 common ophthalmic diseases such as diabetic retinopathy, macular degeneration, glaucoma, etc. It represents the international advanced level of ophthalmic medical image artificial intelligence analysis and diagnosis, and can be better applied to primary screening and hospital auxiliary diagnosis.

In the communication with General Manager Chen, Deputy Director Tao inquired in detail about the MIAS demonstration center jointly built by Big Vision Medical and domestic famous ophthalmic medical institutions. When he learned that MIAS had been clinically verified to be excellent in various performance indicators, he gave a high evaluation of the products and technology of Big Vision Medical. He encouraged Big Vision Medical to maintain cutting-edge research and development capabilities, accelerate enterprise development, and actively promote the application of artificial intelligence in ophthalmic diagnosis and treatment, so as to make greater contributions to the development of medical artificial intelligence in China.

Big Vision has been committed to becoming a top international artificial intelligence company with the mission of “detecting every pair of eyes with problems early and giving the best treatment solution” and adhering to the enterprise spirit of “Dream, Passion, Doing”.